NCT01035164 - Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions

Positron-Emission TomographyAlzheimer's Disease

Interventions

DRUG

F-18 FEDAA1106 (BAY85-8101)

Alzheimer Disease patients: Single intravenous bolus injection of 250 MBq BAY85-8101 on day one of the treatment period, PET

DRUG

F-18 FEDAA1106 (BAY85-8101)

Healthy volunteers for brain imaging: Single intravenous bolus injection of 250 MBq BAY85-8101 on day one of the treatment period, PET

DRUG

F-18 FEDAA1106 (BAY85-8101)

Healthy volunteers for whole body imaging: Single intravenous bolus injection of 185 MBq BAY85-8101, whole body PET for evaluation of effective dose, kinetics of BAY85-8101 in blood

Trial Locations (3)

1081 HV

Amsterdam

141 86

Stockholm

171 76

Stockholm